D. E. Shaw & Co., Inc. Ginkgo Bioworks Holdings, Inc. Call Options Transaction History
D. E. Shaw & Co., Inc.
- $98.6 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DNA
# of Institutions
145Shares Held
499MCall Options Held
937KPut Options Held
2.17M-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$601 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$361 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT10.4MShares$89.1 Million0.01% of portfolio
-
Jane Street Group, LLC New York, NY4.98MShares$42.8 Million0.0% of portfolio
-
Titleist Asset Management, Ltd. San Antonio, TX2.31MShares$19.9 Million0.92% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $11.1B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...